Non-Mucinous Lepidic Predominant Adenocarcinoma Presenting with Extensive Aerogenous Spread
نویسندگان
چکیده
An extremely rare case of non-mucinous lepidic-predominant invasive adenocarcinoma (LPA) showing extensive aerogenous spread with a pneumonic presentation is reported. A 73-year-old woman was referred to our hospital because of an infiltrative shadow on chest xray. Chest computed tomography revealed extensive ground glass opacities in the right lower lobe, which was accompanied by infiltrative shadow with a pneumonic presentation. Invasive mucinous adenocarcinoma was presumed, and a partial resection of the right lower lobe was done. Histopathological examination revealed lepidic growth-predominant invasive adenocarcinoma with Clara type tumor cells, and there were innumerable aerogenous metastases also consisting of Clara cells. Because Alcian Blue and periodic acid-Schiff staining disclosed no mucus, the tumor was diagnosed as a non-mucinous LPA. The patient showed a poor response to 5 courses of pemetrexed, and she died one year after the diagnosis due to cancer progression. Nonmucinous LPA showed a rare presentation characterized by extensive aerogenous spread followed by a poor prognosis.
منابع مشابه
Managing multifocal bronchioloalveolar carcinoma/lepidic predominant adenocarcinoma: changing rules for an evolving clinical entity.
Although the clinical entity of bronchioloalveolar carcinoma (BAC) has been reclassified into adenocarcinoma in situ, lepidic predominant adenocarcinoma, and mucinous adenocarcinoma, it continues to merit special consideration based on its distinct natural history and response to therapy. The clinical behavior of multifocal BAC is highly variable, as is its response to various treatments. This ...
متن کاملThe percentage of lepidic growth is an independent prognostic factor in invasive adenocarcinoma of the lung
BACKGROUND The literature is inconclusive as to whether the percentage of the lepidic component of an invasive adenocarcinoma (AC) of the lung influences prognosis. We studied a population-based series of selected, resected invasive pulmonary ACs to determine if incremental increases in the lepidic component were an independent, prognostic variable. METHODS Patients undergoing resection for l...
متن کاملShould the treatment of advanced lepidic adenocarcinoma be adapted to the pathological subtype?
In 2011, the pathological classification of lung adenocarcinoma was jointly revised by the International Association for the Study of Lung Cancer, the American Thoracic Society and the European Respiratory Society [1]. The former terminology adenocarcinoma with bronchiololalveolar features was recategorised as nonmucinous lepidic predominant adenocarcinoma (NM L-ADC) or mucinous variant (M L-AD...
متن کاملIdentification of lung adenocarcinoma mutation status based on histologic subtype: Retrospective analysis of 269 patients
BACKGROUND To evaluate differences in the clinical characteristics and molecular pathology of lung adenocarcinoma subtypes as defined by the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international histological classification. METHODS We retrospectively reviewed 269 patients with initial primary lung adenocarcinoma who had...
متن کاملPro-tumoural CXCL10/CXCR3-A autocrine loop in invasive mucinous lung adenocarcinoma
Invasive mucinous adenocarcinoma (IMA) is a mucinous variant of lepidic predominant lung adenocarcinoma (LPA) and associated with a worse prognosis. We postulated that cytokine expression would enable us to differentiate IMA from LPA in terms of prognosis and acquisition of pro-tumoural capacities. A 30-cytokine panel was assessed in bronchoalveolar lavage fluids (BALF) from IMA (n=38), LPA (n=...
متن کامل